Search by Drug Name or NDC
NDC 00338-1113-04 CLINIMIX E 880; 489; 33; 5; 438; 204; 255; 311; 247; 51; 170; 238; 261; 289; 213; 297; 77; 179; 77; 17; 247 mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL Details
CLINIMIX E 880; 489; 33; 5; 438; 204; 255; 311; 247; 51; 170; 238; 261; 289; 213; 297; 77; 179; 77; 17; 247 mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL
CLINIMIX E is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is ALANINE; ARGININE; CALCIUM CHLORIDE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; MAGNESIUM CHLORIDE; METHIONINE; PHENYLALANINE; POTASSIUM PHOSPHATE, DIBASIC; PROLINE; SERINE; SODIUM ACETATE; SODIUM CHLORIDE; THREONINE; TRYPTOPHAN; TYROSINE;.
Product Information
| NDC | 00338-1113 |
|---|---|
| Product ID | 0338-1113_814fe2b3-f533-4ef2-912f-07b2baa55b99 |
| Associated GPIs | 80302020552032 |
| GCN Sequence Number | 083075 |
| GCN Sequence Number Description | amino ac 4.25% no.1/D5W/lytes IV SOLN 4.25 % INTRAVEN |
| HIC3 | C9C |
| HIC3 Description | PARENTERAL AMINO ACID SOLUTIONS AND COMBINATIONS |
| GCN | 51919 |
| HICL Sequence Number | 047821 |
| HICL Sequence Number Description | AMINO ACID 4.25 % COMB NO.1/DEXTROSE 5 %/ELECTROLYTES NO.39 |
| Brand/Generic | Brand |
| Proprietary Name | CLINIMIX E |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Sodium Acetate, Dibasic Potassium Phosphate, Magnesium Chloride, Sodium Chloride, Calcium Chloride, De |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 880; 489; 33; 5; 438; 204; 255; 311; 247; 51; 170; 238; 261; 289; 213; 297; 77; 179; 77; 17; 247 |
| Active Ingredient Units | mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL |
| Substance Name | ALANINE; ARGININE; CALCIUM CHLORIDE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; MAGNESIUM CHLORIDE; METHIONINE; PHENYLALANINE; POTASSIUM PHOSPHATE, DIBASIC; PROLINE; SERINE; SODIUM ACETATE; SODIUM CHLORIDE; THREONINE; TRYPTOPHAN; TYROSINE; |
| Labeler Name | Baxter Healthcare Corporation |
| Pharmaceutical Class | Amino Acid [EPC], Amino Acids [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Mot |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020678 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00338-1113-04 (00338111304)
| NDC Package Code | 0338-1113-04 |
|---|---|
| Billing NDC | 00338111304 |
| Package | 2000 mL in 1 BAG (0338-1113-04) |
| Marketing Start Date | 1997-03-26 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |